Pacific Biosciences of California (NASDAQ:PACB) PT Lowered to $8.00

Pacific Biosciences of California (NASDAQ:PACB – Get Rating) had its target price lowered by investment analysts at Cowen to $8.00 in a report released on Tuesday, Stock Target Advisor reports. Cowen’s price target indicates a potential upside of 4.03% from the stock’s current price.
A number of other research analysts have also issued reports on the stock. Cantor Fitzgerald decreased their target price on shares of Pacific Biosciences of California from $23.00 to $19.00 in a research report on Thursday, May 5th.